Literature DB >> 35757312

Errors in antibiotic sensitivity testing: Barking up the wrong tree.

Harit Kumar1, Nitin Kumar2.   

Abstract

Entities:  

Year:  2022        PMID: 35757312      PMCID: PMC9214820          DOI: 10.1016/j.amsu.2022.104015

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


× No keyword cloud information.
Dear Editor, We read a recently published study titled “Twelve-year trend of Escherichia coli antibiotic resistance in the Islamabad population” with an interest to know about the antibiotic susceptibility trend of uropathogenic Escherichia coli causing uncomplicated urinary tract infections (UTI) [1]. The study has reported the retrospective data of twelve years in two phases; first from 1st Jan 2005 to Dec 2010 and second from 1st Jan 2016 to 31st May 2021. However, there are few points in this study which need to be reviewed urgently- Antimicrobial Susceptibility Testing (AST) is a standardized procedure which need to be performed and interpreted as per the recommended guidelines like Clinical and Laboratory Standards Institute (CLSI) or European Committee on Antimicrobial Susceptibility Testing (EUCAST). However, the authors in this study have not mentioned at all about any guidelines to conduct AST and interpretation of the results [2,3]. The Authors have wrongly chosen and documented the concentrations of different antibiotics (Table 1) which were tested against the uropathogenic E. coli strains. Moreover, the authors have just mentioned the name of antibiotic groups like Aminoglycosides and Cephalosporins but there are several antibiotics in each group which may not be tested using the same concentration. For instance, the potency of Gentamicin and Amikacin varies from each other.
Table 1

CLSI/EUCAST recommended potency of antibiotics.

S. No.AntibioticsPotency as mentioned in the present studyRecommended potency by CLSI/EUCAST
1Amoxicillin/Clavulanic acid625mg/1 gm20/10 μg
2Trimethoprim/Sulphamethoxazole160/800 mg1.25/23.75 μg
3Aminoglycosides80mg/500 mgGentamicin- 10 μgAmikacin- 30 μg
4Nitrofurantoin3 gm300 μg
5Cephalosporins400 mg30 μg
6Sulbactams1 gm/2 gmNot to be used alone
7Fosfomycin100 mg200 μg
CLSI/EUCAST recommended potency of antibiotics. Sulbactam, which is a beta-lactamase inhibitor and is recommended to be tested only in combination like Ampicillin-sulbactam etc., was tested alone and reported as 75% sensitive against uropathogenic E. coli in 2021 in this study [2,3]. There are different methods of performing antimicrobial susceptibility testing like diffusion method, dilution method, diffusion and dilution method etc. whereas the authors have not mentioned the name of method, opted in this study [4,5]. In conclusion, the authors have used non-recommended antibiotics concentrations and an unknown methodology and therefore, the results of this study can not be accepted as the antibiotic resistance being a most critical issue for public health.

Ethical approval

Not applicable.

Source of funding

Not applicable.

Author contributions

Both, Dr. Nitin Kumar and Mr. Harit Kumar have equally contributed in writing the final manuscript.

Research registration number

1.Name of the registry: NA 2.Unique Identifying number or registration ID: NA 3.Hyperlink to your specific registration (must be publicly accessible and will be checked): NA

Guarantor

Not applicable.

Consent

Not applicable.

Declaration of competing interest

The authors declare no conflicts of interest in this communication.
  2 in total

Review 1.  Antimicrobial susceptibility testing: a review of general principles and contemporary practices.

Authors:  James H Jorgensen; Mary Jane Ferraro
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

Review 2.  In vitro antimicrobial susceptibility testing methods: agar dilution to 3D tissue-engineered models.

Authors:  A Schumacher; T Vranken; A Malhotra; J J C Arts; P Habibovic
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-04       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.